Delphi panel to understand the real-world occurrence and management of ofatumumab injection-related reactions among healthcare providers of people with relapsing multiple sclerosis
This study gives health care providers insight into the potential occurrence and management of IRRs with ofatumumab in the clinical practice setting.
Authors
- Benjamin Greenberg (ORCID: https://orcid.org/0000-0002-2091-8201)
- Marlon Graf (ORCID: https://orcid.org/0000-0002-6240-8867)
- Rozanne Wilson (ORCID: https://orcid.org/0000-0001-7845-0704)
- Brandon Brown (ORCID: https://orcid.org/0000-0002-6348-4108)
- Shiv Saidha (ORCID: https://orcid.org/0000-0001-6387-0714)
- John F. Kramer (ORCID: https://orcid.org/0000-0003-1799-8623)
- Iris Brewer
- Jacquelyn W. Chou (ORCID: https://orcid.org/0000-0001-9880-6894)
Institutions
- Novartis (Switzerland) (CH)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Novartis (United States) (US)
- MD Precision (Canada) (CA)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Multiple Sclerosis Journal - Experimental Translational and Clinical
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1177/20552173251355677
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Novartis Pharmaceuticals Corporation